184
Views
9
CrossRef citations to date
0
Altmetric
Case Report

Treatment of the aged hand with injectable poly-l-lactic acid

, &
Pages 284-287 | Received 20 Jul 2010, Accepted 28 Oct 2010, Published online: 10 Dec 2010

References

  • Bains RD, Thorpe H, Southern S. Hand aging: Patients’ opinions. Plast Reconstr Surg. 2006;117:2212–2218.
  • Coleman SR. Hand rejuvenation with structural fat grafting. Plast Reconstr Surg. 2002;110:1731–1744.
  • Shamma AR, Guy RJ. Laser ablation of unwanted hand veins. Plast Reconstr Surg. 2007;120:2017–2024.
  • Li L, Mac-Mary S, Marsaut D, Sainthillier JM, Nouveau S, Gharbi T, . Age-related changes in skin topography and microcirculation. Arch Dermatol Res. 2006;297:412–416.
  • Jakubietz RG, Jakubietz MG, Kloss D, Gruenert JG. Defining the basic aesthetics of the hand. Aesthetic Plast Surg. 2005;29:546–551.
  • Butterwick KJ. Rejuvenation of the aging hand. Dermatol Clin. 2005;23:515–527, vii.
  • Rotunda AM, Narins RS. Poly-l-lactic acid: A new dimension in soft tissue augmentation. Dermatol Ther. 2006;19: 151–158.
  • Narins RS, Baumann L, Brandt FS, Fagien S, Glazer S, Lowe NJ, . A randomized study of the efficacy and safety of injectable poly-l-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010;62:448–462.
  • Beer K. A single-center, open-label study on the use of injectable poly-l-lactic acid for the treatment of moderate to severe scarring from acne or varicella. Dermatol Surg. 2007;33(suppl 2):S159–S167.
  • Sculptra® Aesthetic [prescribing information]. Bridgewater, NJ: Dermik Laboratories, a business of sanofi-aventis U.S. LLC;2009.
  • Moyle GJ, Lysakova L, Brown S, Sibtain N, Healy J, Priest C, . A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5:82–87.
  • Lowe NJ. Optimizing poly-l-lactic acid use. J Cosmet Laser Ther. 2008;10:43–46.
  • Borelli C, Kunte C, Weisenseel P, Thoma-Greber E, Korting HC, Konz B. Deep subcutaneous application of poly-l-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol. 2005;18:273–278.
  • Moyle GJ, Brown S, Lysakova L, Barton SE. Long-term safety and efficacy of poly-l-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med. 2006;7: 181–185.
  • Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, . Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA. AIDS. 2003;17: 2471–2477.
  • Mest DR, Humble G. Safety and efficacy of poly-l-lactic acid injections in persons with HIV-associated lipoatrophy: The US experience. Dermatol Surg. 2006;32:1336–1345.
  • Narins RS. Minimizing adverse events associated with poly-l-lactic acid injection. Dermatol Surg. 2008;34(suppl 1): S100–S104.
  • Sculptra® [prescribing information]. Bridgewater, NJ: Dermik Laboratories, a business of sanofi-aventis U.S. LLC; 2006.
  • Lam SM, Azizzadeh B, Graivier M. Injectable poly-l-lactic acid (Sculptra): Technical considerations in soft-tissue contouring. Plast Reconstr Surg. 2006;118(suppl):55S–63S.
  • Redaelli A. Cosmetic use of polylactic acid for hand rejuvenation: Report on 27 patients. J Cosmet Dermatol. 2006;5:233–238.
  • Sadick NS, Anderson D, Werschler WP. Addressing volume loss in hand rejuvenation: A report of clinical experience. J Cosmet Laser Ther. 2008;10:237–241.
  • Vleggaar D. Soft-tissue augmentation and the role of poly-l-lactic acid. Plast Reconstr Surg. 2006;118(suppl):46S–54S.
  • Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: Review. Dermatol Surg. 2005;31:1616–1625.
  • Busso M, Applebaum D. Hand augmentation with Radiesse® (calcium hydroxylapatite). Dermatol Ther. 2007;20:385–387.
  • Man J, Rao J, Goldman M. A double-blind, comparative study of nonanimal-stabilized hyaluronic acid versus human collagen for tissue augmentation of the dorsal hands. Dermatol Surg. 2008;34:1026–1031.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.